Life Sciences · Data & AI · Commercial Excellence
Global commercial operations executive with 20 years in pharma and biotech — turning data, AI and digital transformation into measurable impact across European and International markets.
Building the connective tissue between data, technology and commercial strategy — at the intersection where science meets business impact.
My career has been defined by one consistent thread: closing the gap between what data can tell us and what organisations actually do with it. From early business intelligence work in Madrid to leading global data and AI strategy at Novartis, I've built teams, platforms and programs that move companies from insight to action.
I believe that the best commercial leaders in life sciences are those who can hold scientific rigour and commercial pragmatism in the same hand — and who have the organisational influence to make change stick. That's the work I find most energising.
Leading a new global team delivering business value through data and AI-driven customer experiences for HCPs, patients and healthcare organisations across Sales, Marketing, Medical and Access.
Led a 30+ person team covering Novartis Spain's full portfolio — Oncology, Rare Diseases and new launches.
Responsible for developing and executing Novartis Global Digital Strategy in the commercial space.
Applied Lean principles to optimise clinical trial operations while simplifying the operating model.
Responsible for customer engagement and commercial excellence initiatives with a direct focus on P&L impact across China, LATAM and the US.
Head of Corporate Business Analytics at the world's largest travel retail company, covering operational analytics to data innovation initiatives.
Project lead across a range of BI projects in the marketing and sales space, spanning multiple industries.
Designing end-to-end data strategies — from governance and platform architecture to AI use case development — that deliver measurable commercial outcomes in life sciences environments.
Optimising field force effectiveness, launch readiness and brand performance through analytics, dashboards and structured commercial frameworks across Oncology, Rare Diseases and broader portfolios.
Translating digital vision into organisational change — building the capabilities, culture and engagement models that make personalised, omnichannel customer experience sustainable at scale.
Establishing cross-functional data governance structures and owning enterprise commercial platforms (CRM, MDM, Data Mesh) that provide reliable, trusted foundations for strategic decision-making.
Applying Lean Six Sigma and design thinking to simplify complex operating models — demonstrated through Novartis STRIDE, the largest R&D transformation programme in pharma history.
Building and leading large, globally distributed teams across cultures and functions — with a track record of influencing C-suite stakeholders and driving durable change in matrix organisations.
University of Seville, Spain
Dissertation: Cryptography & Security at ATMs — Honors Cum Laude
EOI Business School, Madrid
Best Programme Thesis Award — "BI Everywhere"
UMS GmbH, Switzerland
Industry standard for process improvement and business excellence
Additional certifications include Drug Research & Development Executive Programmes (Tufts University), Data Science (IBM & University of Washington), and advanced courses in leadership, innovation, and AI. Methodologies: PMP · Scrum · Agile · Design Thinking · Lean Six Sigma.